85 related articles for article (PubMed ID: 25463120)
1. Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome.
Carvalho LS; Virginio VW; Panzoldo NB; Figueiredo VN; Santos SN; Modolo RG; Andrade JM; Quinaglia E Silva JC; Nadruz-Junior W; de Faria EC; Sposito AC;
Atherosclerosis; 2014 Dec; 237(2):777-83. PubMed ID: 25463120
[TBL] [Abstract][Full Text] [Related]
2. HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability.
Carvalho LS; Panzoldo N; Santos SN; Modolo R; Almeida B; Quinaglia E Silva JC; Nadruz W; de Faria EC; Sposito AC;
Atherosclerosis; 2014 Dec; 237(2):840-6. PubMed ID: 25463131
[TBL] [Abstract][Full Text] [Related]
3. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction.
Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L
J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559
[TBL] [Abstract][Full Text] [Related]
4. High sodium intake adversely affects oxidative-inflammatory response, cardiac remodelling and mortality after myocardial infarction.
Costa AP; de Paula RC; Carvalho GF; Araújo JP; Andrade JM; de Almeida OL; de Faria EC; Freitas WM; Coelho OR; Ramires JA; Quinaglia e Silva JC; Sposito AC;
Atherosclerosis; 2012 May; 222(1):284-91. PubMed ID: 22436606
[TBL] [Abstract][Full Text] [Related]
5. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
[TBL] [Abstract][Full Text] [Related]
6. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
Moura FA; Figueiredo VN; Teles BS; Barbosa MA; Pereira LR; Costa AP; Carvalho LS; Cintra RM; Almeida OL; Quinaglia E Silva JC; Nadruz Junior W; Sposito AC;
Atherosclerosis; 2015 Nov; 243(1):124-30. PubMed ID: 26385505
[TBL] [Abstract][Full Text] [Related]
7. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
[TBL] [Abstract][Full Text] [Related]
8. Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
Hermann F; Enseleit F; Spieker LE; Périat D; Sudano I; Hermann M; Corti R; Noll G; Ruschitzka F; Lüscher TF
Thromb Res; 2009; 123(3):460-5. PubMed ID: 18789492
[TBL] [Abstract][Full Text] [Related]
9. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
Isaacs A; Aulchenko YS; Hofman A; Sijbrands EJ; Sayed-Tabatabaei FA; Klungel OH; Maitland-van der Zee AH; Stricker BH; Oostra BA; Witteman JC; van Duijn CM
J Clin Endocrinol Metab; 2007 Jul; 92(7):2680-7. PubMed ID: 17440012
[TBL] [Abstract][Full Text] [Related]
10. Peri-infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction.
Quinaglia e Silva JC; Coelho-Filho OR; Andrade JM; Quinaglia T; Modolo RG; Almeida BO; van der Geest RJ; Jerosch-Herold M; Coelho OR; Sposito AC;
Inflammation; 2014 Jun; 37(3):678-85. PubMed ID: 24282109
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
12. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
[TBL] [Abstract][Full Text] [Related]
13. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
Yilmaz H; Agachan B; Karaali ZE; Isbir T
Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
[TBL] [Abstract][Full Text] [Related]
14. The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction.
Wanschel ACBA; Guizoni DM; Lorza-Gil E; Salerno AG; Paiva AA; Dorighello GG; Davel AP; Balkan W; Hare JM; Oliveira HCF
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430172
[TBL] [Abstract][Full Text] [Related]
15. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
[TBL] [Abstract][Full Text] [Related]
16. The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction.
Gomaraschi M; Sinagra G; Serdoz LV; Pitzorno C; Fonda M; Cattin L; Calabresi L; Franceschini G
Atherosclerosis; 2009 Jan; 202(1):304-11. PubMed ID: 18486943
[TBL] [Abstract][Full Text] [Related]
17. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
[TBL] [Abstract][Full Text] [Related]
18. Total occlusion of the infarct-related coronary artery correlates with brachial artery flow-mediated dilation in patients with ST-elevation myocardial infarction.
Vasilieva E; Urazovskaya I; Skrypnik D; Shpektor A
Acute Card Care; 2009; 11(3):155-9. PubMed ID: 19199114
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein levels are strongly associated with the recovery rate of insulin sensitivity during the acute phase of myocardial infarction: a study by euglycemic hyperinsulinemic clamp.
Carvalho LS; Martins NV; Moura FA; Cintra RM; Almeida OL; Quinaglia e Silva JC; Sposito AC;
J Clin Lipidol; 2013; 7(1):24-8. PubMed ID: 23351579
[TBL] [Abstract][Full Text] [Related]
20. Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).
Abbate A; Van Tassell BW; Christopher S; Abouzaki NA; Sonnino C; Oddi C; Carbone S; Melchior RD; Gambill ML; Roberts CS; Kontos MC; Peberdy MA; Toldo S; Vetrovec GW; Biondi-Zoccai G; Dinarello CA
Am J Cardiol; 2015 Jan; 115(1):8-12. PubMed ID: 25456867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
